HL-8
HL-8 is a PI3Kα PROTAC degrader. HL-8 promotes the ubiquitination and degradation of PI3Kα. HL-8 reduces pAKT levels. HL-8 has anticancer activity against colon and cervical cancer (Pink: PI3Kα ligand ; Blue: E3 ligase VHL ligand (HY-138678) ; Black: linker (HY-W002042) ).
Product Specifications
CAS Number
2766352-64-9
UNSPSC
12352005
Target
Akt; PI3K; PROTACs
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hl-8.html
Purity
99.17
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=NC=C(C=C1NS(=O)(C2=C(C=C(C=C2)F)F)=O)C3=CN4C(C5=NN=C(O5)C6=C(C=CC=C6)C(NCCCCCCC(N[C@@H](C(C)(C)C)C(N7C[C@H](C[C@@H]7C(NCC8=CC=C(C=C8)C9=C(N=CS9)C)=O)O)=O)=O)=O)=CN=C4C=C3
Molecular Formula
C57H59F2N11O9S2
Molecular Weight
1144.27
References & Citations
[1]Wang H, et al. Design, synthesis and activity study of a novel PI3K degradation by hijacking VHL E3 ubiquitin ligase. Bioorg Med Chem. 2022 May 1;61:116707.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC943136-100 1x 100 µL
Langerin / CD207 (Marker of Langerhans Cells) (LGRN/3136R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNUB0820-500 1x 500 µL
Caldesmon, HMW (h-Caldesmon) (CALD1/820), 0.2mg/mL
Sign In for Pricing
View Details 
E-BC-K568-M 96 T (80 samples)
Leucine Aminopeptidase (LAP) Activity Assay Kit
Sign In for Pricing
View Details 
PKSM041027-01 10 µg
Recombinant Mouse Frizzled 1/FZD1 Protein (Fc Tag)
Sign In for Pricing
View Details PKSM041027-02 50 µg
Recombinant Mouse Frizzled 1/FZD1 Protein (Fc Tag)
Sign In for Pricing
View Details